New Delhi: ICICI Direct Research gave a Buy rating on Infosys, Deepak Nitrite and Natco Pharma. The brokerage firm recommended buying the three stocks with a 3-month perspective to earn profits. It suggested share target price and Stop Loss for the mentioned stocks.
Infosys share price target
ICICI Direct maintained Buy rating on IT major Infosys, recommending the large cap stock to be purchased in the range of Rs 1,850-1,895 with a target price of Rs 2,110. The firm advised the shareholders to maintain the Stop Loss at Rs 1,768.
In its Q1 Results 2024-25, Infosys said it delivered $4,714 million in Q1 revenues with a sequential growth of 3.6 per cent and year on year growth of 2.5 per cent in constant currency. The Operating margin stood at 21.1 per cent, a sequential expansion of 1 per cent.
Deepak Nitrite share price target
Backing Deepak Nitrite shares to perform well in the next three months, the brokerage said interested investors can buy the stock in the range of Rs 2,820-2,885. It stated that the scrip has the potential to rise to the levels of Rs 3,275. The scrip should be safeguarded by maintaining the Stop Loss at Rs 2,668.
Deepak Nitrite has been in existence since 1970 and has a portfolio of over 100 international quality products.
Natco Pharma share price target
ICICI Direct suggested buying Natco Pharma shares in the range of Rs 1,490-1525. The brokerage projected the stock to rise to the levels of Rs 1,700 in the next three months. The stock should be safeguarded by positioning the Stop Loss at Rs 1,425, it advised.
In FY 2023-24, NATCO reported consolidated total revenue of Rs 41,269 million as against Rs 28,117 million for the last year. The net profit for the period, on a consolidated basis, was Rs 13,883 million, as against Rs 7,153 million last year.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)
Stocks to invest in for long term: Buy shares of Infosys, Deepak Nitrite and Natco Pharma with a three-month perspective, ICICI Direct Research said. Markets Business News – Personal Finance News, Share Market News, BSE/NSE News, Stock Exchange News Today
